Scott D Grosse
Biographic Data
| ID | 4375207 |
|---|---|
| NAME | Scott D Grosse |
| GIVEN NAMES | Scott D |
| FAMILY NAME | Grosse |
| SIGNATURE | GROSSE S D |
| AFFILIATIONS | University of Michigan |
| ORCID | 0000-0003-1078-6855 |
| VERIFIED | Yes |
| TOTAL WORKS | 19 |
| TOTAL CITATIONS | 10 |
| WORKS AS AUTHOR | 19 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1981 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Professional Fees for U.S. Hospital Care, 2016–2020
BACKGROUND: The latest comprehensive diagnosis-specific estimates of hospital professional fees relative to facility fees are from 2004 to 2012. OBJECTIVE: Update professional fee ratio (PFR) estimates to improve cost analysis opportunities with hospital discharge data sources and compare them with previous PFR estimates. SUBJECTS: 2016-2020 MarketScan inpatient admissions and emergency department (ED) treat and release claims. MEASURES: PFR was …
Advancing Data Capacity for Economic Outcomes in Patient-Centered Outcomes Research
The economic impacts of health care treatments and services on individuals and their families are central to many decisions people make about the use of health care. However, without the high-quality data needed to generate evidence on the clinical effectiveness and economic impacts of an intervention, decision-makers are generally limited in their ability to make informed health care decisions that reflect patient values and preferences. The imp…
National Health Care Expenditures Associated With Disability
BACKGROUND: In 2003, national disability-associated health care expenditures (DAHE) were $398 billion. Updated estimates will improve our understanding of current DAHE. OBJECTIVE: The objective of this study was to estimate national DAHE for the US adult population and analyze spending by insurance and service categories and to assess changes in spending over the past decade. RESEARCH DESIGN: Data from the 2013-2015 Medical Expenditure Panel Surv…
US State-Level Infertility Insurance Mandates and Health Plan Expenditures on Infertility Treatments
Evaluating Harms in the Assessment of Net Benefit
Professional Fee Ratios for US Hospital Discharge Data
BACKGROUND: US hospital discharge datasets typically report facility charges (ie, room and board), excluding professional fees (ie, attending physicians' charges). OBJECTIVES: We aimed to estimate professional fee ratios (PFR) by year and clinical diagnosis for use in cost analyses based on hospital discharge data. SUBJECTS: The subjects consisted of a retrospective cohort of Truven Health MarketScan 2004-2012 inpatient admissions (n=23,594,605) …
Measuring health and well-being effects in family caregivers of children with craniofacial malformations
Ethical implications and practical considerations of ethnically targeted screening for genetic disorders
The prevalence of hemoglobinopathies differs among populations due to genetic differences and due to the protective effects of the heterozygote (carrier) state against malaria. Because of the difference in genetic distribution, public health programs have weighed the ethical versus practical implications of ethnically targeted versus universal newborn, and where applicable, prenatal screening. We examine newborn and prenatal screening for hemoglo…
Points to consider in assessing and appraising predictive genetic tests
The use of predictive genetic tests is expanding rapidly. Given limited health care budgets and few national coverage decisions specifically for genetic tests, evidence of benefits and harms is a key requirement in decision making; however, assessing the benefits and harms of genetic tests raises a number of challenging issues. Frequently, evidence of medical benefits and harms is limited due to practical and ethical limitations of conducting mea…
Economic Productivity by Age and Sex
BACKGROUND: Human capital estimates of labor productivity are often used to estimate the economic impact of diseases and injuries that cause incapacitation or death. OBJECTIVES: Estimates of average hourly, annual, and lifetime economic productivity, both market and household, were calculated in 2007 US dollars for 5-year age groups for men, women, and both sexes in the United States. RESEARCH DESIGN: Data from the American Time Use Survey were u…
Health state preference scores for children with permanent childhood hearing loss
The Business Case for Preconception Care
Only a limited number of economic evaluations have addressed the costs and benefits of preconception care. In order to persuade health care providers, payers, or purchasers to become actively involved in promoting preconception care, it is important to demonstrate the value of doing so through development of a "business case". Perceived benefits in terms of organizational reputation and market share can be influential in forming a business case. …
Health state preference scores of children with spina bifida and their caregivers
Reevaluating the Benefits of Folic Acid Fortification in the United States
Before a 1996 US regulation requiring fortification of enriched cereal-grain products with folic acid, 3 economic evaluations projected net economic benefits or cost savings of folic acid fortification resulting from the prevention of pregnancies affected by a neural tube defect. Because the observed decline in neural tube defect rates is greater than was forecast before fortification, the economic gains are correspondingly larger. Applying both …
The politics of family planning in the Maghrib
On the Alleged Antebellum Surge in Wage Differentials
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content
Regime Type and Performance
Peer Reviewed
Spectrum
Spectrum
Reevaluating the Benefits of Folic Acid Fortification in the United States
Before a 1996 US regulation requiring fortification of enriched cereal-grain products with folic acid, 3 economic evaluations projected net economic benefits or cost savings of folic acid fortification resulting from the prevention of pregnancies affected by a neural tube defect. Because the observed decline in neural tube defect rates is greater than was forecast before fortification, the economic gains are correspondingly larger. Applying both …
Ethical implications and practical considerations of ethnically targeted screening for genetic disorders
The prevalence of hemoglobinopathies differs among populations due to genetic differences and due to the protective effects of the heterozygote (carrier) state against malaria. Because of the difference in genetic distribution, public health programs have weighed the ethical versus practical implications of ethnically targeted versus universal newborn, and where applicable, prenatal screening. We examine newborn and prenatal screening for hemoglo…
The politics of family planning in the Maghrib
On the Alleged Antebellum Surge in Wage Differentials
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content
Regime Type and Performance
Peer Reviewed
Spectrum
Spectrum
The politics of family planning in the Maghrib
On the Alleged Antebellum Surge in Wage Differentials
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content
Regime Type and Performance
Peer Reviewed
Health state preference scores of children with spina bifida and their caregivers
Reevaluating the Benefits of Folic Acid Fortification in the United States
Before a 1996 US regulation requiring fortification of enriched cereal-grain products with folic acid, 3 economic evaluations projected net economic benefits or cost savings of folic acid fortification resulting from the prevention of pregnancies affected by a neural tube defect. Because the observed decline in neural tube defect rates is greater than was forecast before fortification, the economic gains are correspondingly larger. Applying both …
The Business Case for Preconception Care
Only a limited number of economic evaluations have addressed the costs and benefits of preconception care. In order to persuade health care providers, payers, or purchasers to become actively involved in promoting preconception care, it is important to demonstrate the value of doing so through development of a "business case". Perceived benefits in terms of organizational reputation and market share can be influential in forming a business case. …
Health state preference scores for children with permanent childhood hearing loss
Economic Productivity by Age and Sex
BACKGROUND: Human capital estimates of labor productivity are often used to estimate the economic impact of diseases and injuries that cause incapacitation or death. OBJECTIVES: Estimates of average hourly, annual, and lifetime economic productivity, both market and household, were calculated in 2007 US dollars for 5-year age groups for men, women, and both sexes in the United States. RESEARCH DESIGN: Data from the American Time Use Survey were u…
Points to consider in assessing and appraising predictive genetic tests
The use of predictive genetic tests is expanding rapidly. Given limited health care budgets and few national coverage decisions specifically for genetic tests, evidence of benefits and harms is a key requirement in decision making; however, assessing the benefits and harms of genetic tests raises a number of challenging issues. Frequently, evidence of medical benefits and harms is limited due to practical and ethical limitations of conducting mea…
Measuring health and well-being effects in family caregivers of children with craniofacial malformations
Ethical implications and practical considerations of ethnically targeted screening for genetic disorders
The prevalence of hemoglobinopathies differs among populations due to genetic differences and due to the protective effects of the heterozygote (carrier) state against malaria. Because of the difference in genetic distribution, public health programs have weighed the ethical versus practical implications of ethnically targeted versus universal newborn, and where applicable, prenatal screening. We examine newborn and prenatal screening for hemoglo…
Professional Fee Ratios for US Hospital Discharge Data
BACKGROUND: US hospital discharge datasets typically report facility charges (ie, room and board), excluding professional fees (ie, attending physicians' charges). OBJECTIVES: We aimed to estimate professional fee ratios (PFR) by year and clinical diagnosis for use in cost analyses based on hospital discharge data. SUBJECTS: The subjects consisted of a retrospective cohort of Truven Health MarketScan 2004-2012 inpatient admissions (n=23,594,605) …
Evaluating Harms in the Assessment of Net Benefit
US State-Level Infertility Insurance Mandates and Health Plan Expenditures on Infertility Treatments
National Health Care Expenditures Associated With Disability
BACKGROUND: In 2003, national disability-associated health care expenditures (DAHE) were $398 billion. Updated estimates will improve our understanding of current DAHE. OBJECTIVE: The objective of this study was to estimate national DAHE for the US adult population and analyze spending by insurance and service categories and to assess changes in spending over the past decade. RESEARCH DESIGN: Data from the 2013-2015 Medical Expenditure Panel Surv…
Professional Fees for U.S. Hospital Care, 2016–2020
BACKGROUND: The latest comprehensive diagnosis-specific estimates of hospital professional fees relative to facility fees are from 2004 to 2012. OBJECTIVE: Update professional fee ratio (PFR) estimates to improve cost analysis opportunities with hospital discharge data sources and compare them with previous PFR estimates. SUBJECTS: 2016-2020 MarketScan inpatient admissions and emergency department (ED) treat and release claims. MEASURES: PFR was …
Advancing Data Capacity for Economic Outcomes in Patient-Centered Outcomes Research
The economic impacts of health care treatments and services on individuals and their families are central to many decisions people make about the use of health care. However, without the high-quality data needed to generate evidence on the clinical effectiveness and economic impacts of an intervention, decision-makers are generally limited in their ability to make informed health care decisions that reflect patient values and preferences. The imp…
Medicine (13 works) · Economics (8 works) · Business (7 works) · Health care (7 works) · Public health (7 works) · Nursing (6 works) · Economic growth (5 works) · Health Systems, Economic Evaluations, Quality of Life (5 works) · Healthcare Policy and Management (5 works) · Psychology (5 works)